Voyager Therapeutics | search
Click here to view Voyager Therapeutics news from 60+ newspapers.
Bookmark or Share- About – Overview - Voyager TherapeuticsMission. To create disease-modifying neurogenetic medicines by identifying validated targets, advancing multiple therapeutic modalities, and delivering to the right areas within the central nervous system. Vision, Mission & Strategy. Voyager’s leaders bring deep expertise in biopharmaceutical development, neurotherapeutics, genetic medicines ...
- Science – Overview - Voyager TherapeuticsNon-Viral Approaches. Multiple modalities to treat neurological diseases. The Voyager team has expertise in the discovery and development of monoclonal antibodies as well as in receptor-mediated non-viral delivery to the central nervous system. Learn More.
- Voyager Therapeutics, Inc. (VYGR) - Yahoo FinanceVoyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody ...
- Voyager Therapeutics - Defining Neurogenetic MedicineVoyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. About Advancing transformative medicines for neurological diseases.
- Investors | Voyager Therapeutics Inc.Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of ...
More
